☢ Modality 5

Nuclear Medicine

Nuclear medicine images function, not just structure. By administering radioactive tracers that accumulate in specific tissues, it reveals metabolic activity, receptor density, and physiologic processes invisible to other modalities.

1946
I-131 Clinical Use Begins
Tc-99m
Most Used Radioisotope
6h
Tc-99m Half-Life
140 keV
Tc-99m Gamma Energy

Radioactive Decay & Imaging

Unstable atomic nuclei spontaneously emit radiation as they decay toward a more stable state. Nuclear medicine harnesses this phenomenon by introducing radiolabeled compounds (radiopharmaceuticals) into the body that are taken up by specific tissues.

The key types of decay relevant to nuclear medicine imaging are gamma (γ) decay (for SPECT and planar scintigraphy) and positron (β⁺) emission (for PET scanning).

  • Gamma decay: Nucleus emits a high-energy photon (gamma ray) without changing atomic number. Gamma rays pass through tissue and are detected externally by the gamma camera.
  • Positron emission: A proton converts to a neutron, emitting a positron (β⁺). The positron travels a short distance, then annihilates with an electron to produce two 511 keV photons traveling in exactly opposite directions — detected by PET coincidence detection.
  • Half-life (T½): Time for half the radioactive atoms to decay. Short T½ = less patient dose but requires fast imaging; long T½ = sustained imaging but more dose.
  • Effective half-life: Combined physical decay AND biological elimination — true dose predictor in vivo.
Radioactive Decay Types
GAMMA DECAY β⁺ DECAY (Positron) Tc-99m* Excited Tc-99 Ground state γ 140 keV photon GAMMA CAMERA Detects gamma photons externally → SPECT / planar scintigraphy F-18 (Parent) O-18 (Daughter) β⁺ β⁺ + e⁻ → Annihilation 511 keV 511 keV Detected by PET coincidence detectors (180° apart) → PET image

Radiopharmaceuticals

A radiopharmaceutical = radioactive isotope + pharmaceutical carrier. The pharmaceutical determines where the tracer accumulates in the body; the isotope provides the detectable radiation.

RadioisotopeHalf-LifeEmissionEnergyKey Use
Tc-99m6 hoursGamma (γ)140 keVBone scan, thyroid, cardiac, renal, lung (V/Q)
I-12313 hoursGamma159 keVThyroid imaging, SPECT brain (DATscan)
I-1318 daysBeta (β⁻) + Gamma364 keV γThyroid cancer therapy, remnant ablation
Ga-673.3 daysGamma93–394 keVInfection/inflammation, lymphoma
Tl-20173 hoursX-ray + Gamma69–83 keVCardiac perfusion (older), parathyroid
F-18 FDG110 minPositron (β⁺)511 keV pairsPET oncology, neurology, cardiology
Ga-6868 minPositron (β⁺)511 keV pairsPET PSMA (prostate), somatostatin receptors (NETs)
Lu-1776.7 daysBeta (β⁻) + Gamma208 keV γPRRT therapy (NETs), PSMA therapy (prostate)

Half-Life Activity Calculator

Change the isotope, starting activity, and elapsed time to see how much radioactivity remains. Add biological clearance to estimate effective half-life in the body.

10.00 mCi
Activity remaining
50.0%
Radioactivity left
50.0%
Atoms decayed
1.00
Half-lives passed
A = A0 x (1/2)^(t / T1/2). Tc-99m after 6.0 hours: 20 mCi x 0.500 = 10.00 mCi.

Animated Radioactive Source

The source emits fewer photons as fewer unstable nuclei remain. Lower activity means weaker glow, fewer detected events, and less dose rate over time.

50.0% active
🧪

Why Tc-99m dominates: Its 6-hour half-life is long enough for imaging but short enough to minimize patient dose. Its 140 keV gamma energy is ideal for gamma camera detection. It is produced from Mo-99/Tc-99m generators in hospital radiopharmacies, making it readily available. It can be tagged to dozens of different pharmaceutical carriers for different organ systems.

Gamma Camera — Anger Camera

Click components to learn their function.

Patient (radiopharmaceutical distributed in body) COLLIMATOR (Lead) Rejected Rejected NaI(Tl) SCINTILLATION CRYSTAL Light Guide PHOTOMULTIPLIER TUBES (PMTs) PULSE PROCESSING & POSITIONING ELECTRONICS SCINTIGRAPHIC IMAGE

Gamma Camera Components

Invented by Hal Anger in 1958, the Anger scintillation camera remains the core detector in nuclear medicine. Click components to learn each layer's function.

🔍

The gamma camera detects gamma photons emitted by radiopharmaceuticals inside the patient, creating a 2D projection image (planar scintigraphy) or 3D SPECT images through rotation.

SPECT vs PET

Both SPECT and PET create 3D images of radiopharmaceutical distribution. They differ in the type of isotope used, detection method, and image quality.

Visual Comparison

Side-by-side detector geometry, photon emission, tracer examples, and typical image results for SPECT and PET.

SPECT versus PET infographic comparing single gamma photon detection with positron annihilation coincidence detection, clinical uses, image characteristics, and typical scan results
FeatureSPECTPET
Full nameSingle Photon Emission CTPositron Emission Tomography
Isotope typeGamma emitters (Tc-99m, I-123)Positron emitters (F-18, Ga-68, C-11)
Detection methodRotating gamma cameras + collimatorsCoincidence detection (two 511 keV photons)
Spatial resolution8–12 mm3–5 mm (superior)
SensitivityLower10–100× higher than SPECT
QuantificationSemi-quantitative (SUV limited)Accurate quantification (SUV)
Scan time20–60 min (rotating)10–30 min (stationary ring)
CostLower (Tc-99m from generator)Higher (cyclotron needed for most tracers)
Hybrid scannerSPECT/CTPET/CT or PET/MRI
Main clinical useBone, cardiac, thyroid, renal, lungOncology (FDG-PET), neurology (amyloid), cardiology
💡

PET/CT fusion: Combining a PET scanner with a CT scanner in one unit (PET/CT) allows simultaneous functional (PET) and anatomical (CT) imaging in a single session. The CT provides anatomical localization and attenuation correction for the PET data — this combination revolutionized oncology staging and treatment response assessment.

Clinical Applications

Nuclear medicine uniquely reveals functional information — metabolism, perfusion, receptor density — that anatomical imaging cannot provide.

Whole-body nuclear medicine bone scan showing skeletal radiotracer uptake

🦴 Bone Scan (MDP Tc-99m)

Whole-body bone scan for metastases, stress fractures, osteomyelitis, and Paget's disease. Highly sensitive for bone turnover — detects lesions earlier than plain X-ray.

Nuclear medicine myocardial perfusion SPECT scan of the heart

❤️ Myocardial Perfusion (MPI)

SPECT with Tc-99m sestamibi or Tl-201 to assess coronary artery disease. Stress/rest comparison identifies ischemia vs. infarct. PET with Rb-82 or NH3 for quantitative perfusion.

FDG PET/CT transverse slice showing radiotracer-avid nasopharyngeal cancer

🎗️ FDG-PET Oncology

F-18 fluorodeoxyglucose (FDG) exploits the Warburg effect (increased glucose metabolism in cancer). Used for staging, restaging, and treatment response in lymphoma, lung, colorectal, melanoma, and many other cancers.

Thyroid scintigraphy comparison showing different thyroid uptake patterns

🦋 Thyroid Studies

I-123 thyroid scan: hot (autonomous) vs. cold (suspicious) nodules, Graves' disease uptake. I-131 treatment and ablation for thyroid cancer and hyperthyroidism.

DaTSCAN SPECT image showing striatal radiotracer uptake in the brain

🧠 Neurology PET

FDG-PET for dementia (Alzheimer's vs FTD pattern). Amyloid PET (florbetapir) and tau PET for Alzheimer pathology. DATscan (I-123) for Parkinson's vs. essential tremor.

Nuclear medicine ventilation and perfusion lung scan

🫁 V/Q Scan (Lung)

Tc-99m MAA perfusion + Tc-99m aerosol or Xe-133 ventilation for pulmonary embolism diagnosis. Preferred over CT in pregnancy (lower fetal dose).

☢️

Radiation protection for NM staff: Time, distance, and shielding are key. Keep exposure times minimal during radiopharmaceutical preparation. Tungsten syringe shields and lead-lined waste containers are standard. Pregnant patients — assess risk/benefit; most studies avoided in first trimester.

Radiation as Treatment

Radiotherapy — harnessing high-energy radiation to destroy cancer cells.

Explore Radiotherapy →